PL366116A1 - Administration of nucleic acid sequence to female animal - Google Patents

Administration of nucleic acid sequence to female animal

Info

Publication number
PL366116A1
PL366116A1 PL01366116A PL36611601A PL366116A1 PL 366116 A1 PL366116 A1 PL 366116A1 PL 01366116 A PL01366116 A PL 01366116A PL 36611601 A PL36611601 A PL 36611601A PL 366116 A1 PL366116 A1 PL 366116A1
Authority
PL
Poland
Prior art keywords
administration
nucleic acid
acid sequence
female animal
female
Prior art date
Application number
PL01366116A
Other languages
Polish (pl)
Inventor
Robert J. Schwartz
Robert H. Carpenter
Ruxandra Draghia-Akli
Douglas R. Kern
Roy G. Smith
Original Assignee
Baylor College Of Medicine
Advisys, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baylor College Of Medicine, Advisys, Inc. filed Critical Baylor College Of Medicine
Publication of PL366116A1 publication Critical patent/PL366116A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New breeds of animals
    • A01K67/027—New breeds of vertebrates
    • A01K67/0271—Chimeric animals, e.g. comprising exogenous cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/60—Growth-hormone releasing factors (GH-RF) (Somatoliberin)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00—Modified animals
    • A01K2207/15—Humanized animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/02—Animal zootechnically ameliorated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/008—Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/15—Vector systems having a special element relevant for transcription chimeric enhancer/promoter combination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/80—Vector systems having a special element relevant for transcription from vertebrates
    • C12N2830/85—Vector systems having a special element relevant for transcription from vertebrates mammalian
PL01366116A 2000-12-12 2001-12-12 Administration of nucleic acid sequence to female animal PL366116A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US25502100P 2000-12-12 2000-12-12

Publications (1)

Publication Number Publication Date
PL366116A1 true PL366116A1 (en) 2005-01-24

Family

ID=22966509

Family Applications (1)

Application Number Title Priority Date Filing Date
PL01366116A PL366116A1 (en) 2000-12-12 2001-12-12 Administration of nucleic acid sequence to female animal

Country Status (10)

Country Link
EP (1) EP1364004A4 (en)
KR (1) KR20040039187A (en)
CN (1) CN1575301A (en)
AR (1) AR035671A1 (en)
AU (1) AU2002248194B2 (en)
BR (1) BR0116472A (en)
CA (1) CA2430921C (en)
MX (1) MXPA03005236A (en)
PL (1) PL366116A1 (en)
WO (1) WO2002061037A2 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003038112A2 (en) 2001-10-26 2003-05-08 Baylor College Of Medicine A composition and method to alter lean body mass and bone properties in a subject
MXPA04007638A (en) 2002-02-07 2004-12-06 Baylor College Medicine Modified pituitary gland development in offspring from expectant mother animals treated with growth hormone releasing hormone therapy.
AU2003249208B2 (en) 2002-07-16 2010-03-04 Vgx Pharmaceuticals, Llc Codon optimized synthetic plasmids
DE10240418A1 (en) * 2002-09-02 2004-03-11 Avontec Gmbh Formulation for introducing nucleic acids into eukaryotic cells
AU2003295366B2 (en) * 2002-11-04 2011-11-24 Advisys, Inc. Synthetic muscle promoters with activities exceeding naturally occurring regulatory sequences in cardiac cells
US20040204358A1 (en) * 2003-01-28 2004-10-14 Advisys, Inc. Reducing culling in herd animals growth hormone releasing hormone (GHRH)
CN102127545A (en) * 2010-11-24 2011-07-20 山东农业大学 Skeletal muscle specificity CKM (Creatine Kinase Muscle) promoter and applications thereof
CN104031930B (en) * 2014-05-30 2017-09-22 华南农业大学 A kind of method of nutrition and immune substance content in raising sow milk
CN105219774B (en) * 2015-10-10 2019-04-30 广西大学 Pork insulin specific expressing promoter PIP2 and its application
CN105617404A (en) * 2016-01-27 2016-06-01 广州市科虎生物技术研究开发中心 Application of GRF (growth hormone releasing factor) expression plasmid in preparation of medicines for reducing rate of weak piglets
DE202018105142U1 (en) * 2018-04-29 2018-10-08 Kalmarna Limited - CCS Trustees Limited Compositions for oral administration for influencing the progeny of mammals

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2622455B1 (en) * 1987-11-04 1991-07-12 Agronomique Inst Nat Rech APPLICATION OF THE HUMAN GROWTH HORMONE SECRETION STIMULATION FACTOR, ITS ACTIVE FRAGMENTS AND RELATED ANALOGS, TO INCREASE DAIRY PRODUCTION AND NEWBORN WEIGHT IN MAMMALS
ZA914983B (en) * 1990-06-29 1992-03-25 Hoffmann La Roche His-grf-analogs
US6165755A (en) * 1997-01-23 2000-12-26 University Of Victoria Innovation And Development Corporation Chicken neuropeptide gene useful for improved poultry production
AU8589998A (en) * 1997-07-24 1999-02-16 Valentis, Inc. Ghrh expression system and methods of use
EP1204321B1 (en) * 1999-07-26 2005-11-09 Baylor College Of Medicine Super-active porcine growth hormone releasing hormone analog

Also Published As

Publication number Publication date
EP1364004A4 (en) 2005-11-09
AU2002248194B2 (en) 2007-04-05
WO2002061037A2 (en) 2002-08-08
EP1364004A2 (en) 2003-11-26
BR0116472A (en) 2005-04-05
WO2002061037B1 (en) 2004-01-15
AR035671A1 (en) 2004-06-23
CN1575301A (en) 2005-02-02
CA2430921C (en) 2016-06-07
MXPA03005236A (en) 2005-04-08
WO2002061037A3 (en) 2003-10-02
KR20040039187A (en) 2004-05-10
CA2430921A1 (en) 2002-08-08

Similar Documents

Publication Publication Date Title
IL154031A0 (en) Substituted sulfonylaminomethylbenzoic acid derivatives and preparation
EP1203008A4 (en) Nucleic acid ligands to cd40ligand
HK1061403A1 (en) ANTIBODIES TO HUMAN IL-1ß
AU8148101A (en) Novel process to prepare aqueous formulations
PL366116A1 (en) Administration of nucleic acid sequence to female animal
HUP0302585A3 (en) Lactic acid bacteria capable of reducing an individual's tendency to develop allerreactions
EP1375672A4 (en) Method of detecting nucleic acid relating to disease
AU3408901A (en) Cancer remedy comprising anthranilic acid derivative as active ingredient
EP1584320A4 (en) Cosmetic preparation containing glycerylamino acid derivative
TW478662U (en) Improved structure of flat bus line connector
HUP0302534A3 (en) Preparation of mandelic acid derivatives
GB2375240B (en) Method of connecting flat cable to connecting element
EP1316314A4 (en) Vaccine preparation containing fatty acid as component
HUP0203848A3 (en) Nucleic acid vaccination
GB0217398D0 (en) Method of connecting flat cable to connector
GB9801142D0 (en) Administration of beneficial substances to ruminant animals
AU2001256179A1 (en) Low ph high fatty acid vanishing cream
IL152548A0 (en) Regulatory nucleic acid sequences of the abc1 gene
IL147071A0 (en) Nucleic and proteinic acids corresponding to human gene abc1
DE60117846D1 (en) PREPARATION OF 6-AMINOCAPRIC ACID ALKYLES
GB0022101D0 (en) Delivery of substances to cells
GB0026494D0 (en) Isolation of nucleic acid
TW426237U (en) Structure of female connector
TW464084U (en) Improved structure for female socket of USB connector
TW480917U (en) Improved structure of connector for fishing

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)